AviadoBio Presents Positive Preclinical Data for AVB-406 Program in Alzheimer’s Disease and Other Tauopathies at ASGCT 2026 May 14, 2026 Preclinical AVB-406 data presented in three oral presentations demonstrate the power of the vMiXTM RNAi platform and support planned clinical initiation for Alzheimer’s disease by the end of 2026 Preclinical data show AVB-406 achieved up to 80% MAPT/tau knockdown in the brain
European Aerospace, Defense Firms Advance Modernization May 14, 2026 Companies innovate with AI and new approaches to engineering and operations, ISG Provider Lens® report says
Reply Launches Model Factory, the Production Line for Creating Industrial-Grade Generative AI Models May 14, 2026 Reply [EXM, STAR: REY] announces Reply Model Factory, an industrial production line for building frontier generative AI models grounded in corporate knowledge and designed to power AI systems and agents aligned with each organisation’s operational context. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260514524231/en/ AI models are often built to operate across [...]
ICON expands US early phase research capabilities with new clinic and outpatient centres May 13, 2026 New, 69.5K square-foot, state-of-the-art clinic in Texas integrates clinical, laboratory, and pharmacy infrastructure all under one roof Two new satellite outpatient clinics in Texas and Kansas will further expand recruitment reach and reduce visit burden
Hermes Reply Presents Brick Cognitive, the Agentic Operating System for Manufacturing May 13, 2026 Hermes Reply, the Reply Group company specialized in digital transformation for manufacturing, presents Brick Cognitive, the new agentic operating system designed to bring AI to the centre of industrial operations. A natural extension of Brick Reply, Reply’s next-generation MES/MOM platform, Brick Cognitive introduces a model in which factory systems no longer simply execute and monitor [...]
The Justice Company Launches Human Rights Screened High Dividend ETF via HANetf White-Label Platform May 13, 2026 The Justice Company has entered the European ETF market with the launch of JURY Global High Dividend UCITS ETF (ticker: JURY). JURY aims to provide exposure to high dividend global equities within clearly defined legal and human-rights boundaries. 10% of the TER will be dedicated to initiatives supporting communities affected by conflict, displacement and systemic oppression.1 The ETF is classified as Article 8 under the Sustainable Finance Disclosure Regulation (SFDR).2 JURY is listed on London Stock Exchange, Xetra, and Borsa Italiana. When you invest in ETFs your capital is at risk.
OLX Group Launches Otodim Platform in Ukraine, Deepening Commitment to the Country’s Real Estate Market May 13, 2026 The new dedicated real estate platform builds on OLX Ukraine's active market presence as property search demand grows for renters and buyers
Magnolia Advanced Materials Expands European Presence to Meet Rising Global Demand May 12, 2026 Magnolia Advanced Materials, Inc., a custom formulator of high-performance epoxy systems for aerospace, defense and industrial applications, today announced a Technical Support Center in Edinburgh, Scotland. The location will be managed by a 15-year Magnolia veteran, Gary Betzel, who recently relocated there. The expansion strengthens Magnolia’s ability to provide close technical collaboration, fast response times [...]
Nikkiso Signs Agreement With Maran Tankers Management to Provide Aftermarket Service Support May 12, 2026 Nikkiso Clean Energy & Industrial Gases Group (Nikkiso CE&IG) has announced today that it has signed a long-term service agreement with oil tanker shipping firm Maran Tankers Management Inc. Under the five-year agreement, Nikkiso CE&IG will deliver comprehensive global aftermarket support for Maran Tankers’ high pressure pumps, including scheduled cold end valve repairs at defined [...]
Medisca and dsm–firmenich Partner to Expand Access to Pharmaceutical-Grade Vitamin APIs for U.S. Compounding Market May 12, 2026 Medisca, a global leader in personalized pharmaceutical medicine, has entered into a strategic partnership with dsm–firmenich, a leading ingredient manufacturer serving regulated pharmaceutical markets worldwide. Through this partnership, Medisca will make a portfolio of pharmaceutical-grade vitamin active pharmaceutical ingredients (APIs) available to U.S. compounding professionals, expanding access to ingredients manufactured within European cGMP environments and [...]